Kim HJ - Search Results

1

Current status of and strategies for hepatitis C control in South Korea.

Kim BK, Jang ES, Kim JH, Park SY, Ahn SV, Kim HJ, Kim DY. Kim BK, et al. Among authors: kim hj, kim dy, kim jh. Clin Mol Hepatol. 2017 Sep;23(3):212-218. doi: 10.3350/cmh.2017.0105. Epub 2017 Sep 19. Clin Mol Hepatol. 2017. PMID: 28942625 Free PMC article. Review.

2

Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.

Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, Park SM. Yoo BC, et al. Among authors: kim hj. J Hepatol. 2003 Jan;38(1):98-103. doi: 10.1016/s0168-8278(02)00349-5. J Hepatol. 2003. PMID: 12480566

3

[Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].

Yoo BC, Kim HJ, Do JH, Park SM. Yoo BC, et al. Among authors: kim hj. Taehan Kan Hakhoe Chi. 2002 Dec;8(4):381-8. Taehan Kan Hakhoe Chi. 2002. PMID: 12506242 Korean.

4

Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

Lee JM, Kim HJ, Park JY, Lee CK, Kim DY, Kim JK, Lee HW, Paik YH, Lee KS, Han KH, Chon CY, Hong SP, Nguyen T, Ahn SH. Lee JM, et al. Among authors: kim jk, kim hj, kim dy. Antivir Ther. 2009;14(5):705-12. Antivir Ther. 2009. PMID: 19704174 Clinical Trial.

5

[Efficacy of 48-week clevudine therapy for chronic hepatitis B].

Kim MH, Kim KA, Lee JS, Lee HW, Kim HJ, Yun SG, Kim NH, Bae WK, Moon YS. Kim MH, et al. Among authors: kim hj, kim ka, kim nh. Korean J Hepatol. 2009 Sep;15(3):331-7. doi: 10.3350/kjhep.2009.15.3.331. Korean J Hepatol. 2009. PMID: 19783882 Korean.

6

Important predictor of mortality in patients with end-stage liver disease.

Kim HJ, Lee HW. Kim HJ, et al. Clin Mol Hepatol. 2013 Jun;19(2):105-15. doi: 10.3350/cmh.2013.19.2.105. Epub 2013 Jun 27. Clin Mol Hepatol. 2013. PMID: 23837134 Free PMC article. Review.

7

Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma.

Yang SY, Cha BK, Kim G, Lee HW, Kim JG, Chang SK, Kim HJ. Yang SY, et al. Among authors: kim g, kim hj, kim jg. Korean J Intern Med. 2014 Mar;29(2):231-5. doi: 10.3904/kjim.2014.29.2.231. Epub 2014 Feb 27. Korean J Intern Med. 2014. PMID: 24648807 Free PMC article.

8

Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study.

Lee S, Kim BK, Kim SU, Park SY, Kim JK, Lee HW, Park JY, Kim DY, Ahn SH, Tak WY, Kweon YO, Lee JI, Lee KS, Kim HJ, Han KH. Lee S, et al. Among authors: kim jk, kim su, kim hj, kim dy, kim bk. J Gastroenterol Hepatol. 2014;29(7):1463-9. doi: 10.1111/jgh.12542. J Gastroenterol Hepatol. 2014. PMID: 25273508

9

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir.

Ze E, Baek EK, Lee JJ, Chung HW, Ahn DG, Cho HJ, Kwon JC, Kim HJ, Lee H. Ze E, et al. Among authors: kim hj. Clin Mol Hepatol. 2014 Sep;20(3):267-73. doi: 10.3350/cmh.2014.20.3.267. Epub 2014 Sep 25. Clin Mol Hepatol. 2014. PMID: 25320730 Free PMC article.

10

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea.

Yang SY, Lee HW, Lee YJ, Park SJ, Yoo KY, Kim HJ. Yang SY, et al. Among authors: kim hj. Clin Mol Hepatol. 2015 Jun;21(2):125-30. doi: 10.3350/cmh.2015.21.2.125. Epub 2015 Jun 26. Clin Mol Hepatol. 2015. PMID: 26157749 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,964 results

Search Page